203 related articles for article (PubMed ID: 29581438)
1. Structural modelling of the DNAJB6 oligomeric chaperone shows a peptide-binding cleft lined with conserved S/T-residues at the dimer interface.
Söderberg CAG; Månsson C; Bernfur K; Rutsdottir G; Härmark J; Rajan S; Al-Karadaghi S; Rasmussen M; Höjrup P; Hebert H; Emanuelsson C
Sci Rep; 2018 Mar; 8(1):5199. PubMed ID: 29581438
[TBL] [Abstract][Full Text] [Related]
2. Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation.
Månsson C; van Cruchten RTP; Weininger U; Yang X; Cukalevski R; Arosio P; Dobson CM; Knowles T; Akke M; Linse S; Emanuelsson C
Biochemistry; 2018 Aug; 57(32):4891-4902. PubMed ID: 30024736
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β oligomers are captured by the DNAJB6 chaperone: Direct detection of interactions that can prevent primary nucleation.
Österlund N; Lundqvist M; Ilag LL; Gräslund A; Emanuelsson C
J Biol Chem; 2020 Jun; 295(24):8135-8144. PubMed ID: 32350108
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal domain of the antiamyloid chaperone DNAJB6 binds to amyloid-β peptide fibrils and inhibits secondary nucleation.
Österlund N; Frankel R; Carlsson A; Thacker D; Karlsson M; Matus V; Gräslund A; Emanuelsson C; Linse S
J Biol Chem; 2023 Nov; 299(11):105317. PubMed ID: 37797698
[TBL] [Abstract][Full Text] [Related]
5. DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios.
Månsson C; Kakkar V; Monsellier E; Sourigues Y; Härmark J; Kampinga HH; Melki R; Emanuelsson C
Cell Stress Chaperones; 2014 Mar; 19(2):227-39. PubMed ID: 23904097
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Aβ42) aggregates leads to sub-stoichiometric inhibition of amyloid formation.
Månsson C; Arosio P; Hussein R; Kampinga HH; Hashem RM; Boelens WC; Dobson CM; Knowles TP; Linse S; Emanuelsson C
J Biol Chem; 2014 Nov; 289(45):31066-76. PubMed ID: 25217638
[TBL] [Abstract][Full Text] [Related]
7. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.
Gillis J; Schipper-Krom S; Juenemann K; Gruber A; Coolen S; van den Nieuwendijk R; van Veen H; Overkleeft H; Goedhart J; Kampinga HH; Reits EA
J Biol Chem; 2013 Jun; 288(24):17225-37. PubMed ID: 23612975
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.
Meng E; Shevde LA; Samant RS
Oncotarget; 2016 Aug; 7(33):53984-53996. PubMed ID: 27276715
[TBL] [Abstract][Full Text] [Related]
9. Human J-protein DnaJB6b Cures a Subset of Saccharomyces cerevisiae Prions and Selectively Blocks Assembly of Structurally Related Amyloids.
Reidy M; Sharma R; Roberts BL; Masison DC
J Biol Chem; 2016 Feb; 291(8):4035-47. PubMed ID: 26702057
[TBL] [Abstract][Full Text] [Related]
10. Microsecond Backbone Motions Modulate the Oligomerization of the DNAJB6 Chaperone.
Cawood EE; Clore GM; Karamanos TK
Angew Chem Int Ed Engl; 2022 May; 61(20):e202116403. PubMed ID: 35247211
[TBL] [Abstract][Full Text] [Related]
11. Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy.
Ruggieri A; Brancati F; Zanotti S; Maggi L; Pasanisi MB; Saredi S; Terracciano C; Antozzi C; D Apice MR; Sangiuolo F; Novelli G; Marshall CR; Scherer SW; Morandi L; Federici L; Massa R; Mora M; Minassian BA
Acta Neuropathol Commun; 2015 Jul; 3():44. PubMed ID: 26205529
[TBL] [Abstract][Full Text] [Related]
12. Small angle X-ray scattering analysis of Cu(2+)-induced oligomers of the Alzheimer's amyloid β peptide.
Ryan TM; Kirby N; Mertens HD; Roberts B; Barnham KJ; Cappai R; Pham Cle L; Masters CL; Curtain CC
Metallomics; 2015 Mar; 7(3):536-43. PubMed ID: 25687761
[TBL] [Abstract][Full Text] [Related]
13. DNAJB8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity.
Ryder BD; Ustyantseva E; Boyer DR; Mendoza-Oliva A; Kuska MI; Wydorski PM; Macierzyńska P; Morgan N; Sawaya MR; Diamond MI; Kampinga HH; Joachimiak LA
Structure; 2024 Jun; 32(6):662-678.e8. PubMed ID: 38508190
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the structure and dynamics of the human DNAJB6b chaperone by NMR reveals insights into Hsp40-mediated proteostasis.
Karamanos TK; Tugarinov V; Clore GM
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21529-21538. PubMed ID: 31591220
[TBL] [Abstract][Full Text] [Related]
15. Myofibrillar disruption and RNA-binding protein aggregation in a mouse model of limb-girdle muscular dystrophy 1D.
Bengoechea R; Pittman SK; Tuck EP; True HL; Weihl CC
Hum Mol Genet; 2015 Dec; 24(23):6588-602. PubMed ID: 26362252
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the formation of oligomeric state by a type I Hsp40 chaperone.
Zhu M; Ou D; Khan MH; Zhao S; Zhu Z; Niu L
Biochimie; 2020 Sep; 176():45-51. PubMed ID: 32621942
[TBL] [Abstract][Full Text] [Related]
18. The Hsp40 family chaperone protein DnaJB6 enhances Schlafen1 nuclear localization which is critical for promotion of cell-cycle arrest in T-cells.
Zhang Y; Yang Z; Cao Y; Zhang S; Li H; Huang Y; Ding YQ; Liu X
Biochem J; 2008 Jul; 413(2):239-50. PubMed ID: 18373498
[TBL] [Abstract][Full Text] [Related]
19. High-Efficiency Expression and Purification of DNAJB6b Based on the pH-Modulation of Solubility and Denaturant-Modulation of Size.
Linse S
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056736
[TBL] [Abstract][Full Text] [Related]
20. DNAJB6 myopathy in an Asian cohort and cytoplasmic/nuclear inclusions.
Sato T; Hayashi YK; Oya Y; Kondo T; Sugie K; Kaneda D; Houzen H; Yabe I; Sasaki H; Noguchi S; Nonaka I; Osawa M; Nishino I
Neuromuscul Disord; 2013 Mar; 23(3):269-76. PubMed ID: 23394708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
